articleThe LancetJul 17, 2008Closed access

Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial

PEPaul EmeryFCFerdinand C. BreedveldSHStephen HallPDPatrick DurezDJDavid J. Chang

Chapel Allerton Hospital · University of Leeds · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

816
total citations
FWCI
51.47
Percentile
100%
References
43
Citations per year

Authors

10

Topics & keywords

Topics
Keywords
  • Medicine
  • Rheumatoid arthritis
  • Etanercept
  • Methotrexate
  • Internal medicine
  • Surgery
  • Gastroenterology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.